Molecular and imaging predictors of response to ado-trastuzumab emtansine in patients with HER2 mutant lung cancers: An exploratory phase 2 trial Meeting Abstract
| Authors: | Li, B.; Offin, M.; Hembrough, T.; Cecchi, F.; Shen, R.; Olah, Z.; Panora, E.; Myers, M.; Brzostowski, E.; Buonocore, D.; Ginsberg, M.; Rudin, C.; Kris, M.; Weitsman, G.; Barber, P.; Ng, T.; Ulaner, G.; Arcila, M.; Scaltriti, M. |
| Abstract Title: | Molecular and imaging predictors of response to ado-trastuzumab emtansine in patients with HER2 mutant lung cancers: An exploratory phase 2 trial |
| Meeting Title: | IASLC 19th World Conference on Lung Cancer |
| Keywords: | antibody drug conjugate; her2 mutant lung cancers; her2 targeted imaging |
| Journal Title: | Journal of Thoracic Oncology |
| Volume: | 13 |
| Issue: | 10 Suppl. |
| Meeting Dates: | 2018 Sep 23-26 |
| Meeting Location: | Toronto, Canada |
| ISSN: | 1556-0864 |
| Publisher: | Elsevier Inc. |
| Date Published: | 2018-10-01 |
| Start Page: | S599 |
| Language: | English |
| ACCESSION: | WOS:000454014502055 |
| DOI: | 10.1016/j.jtho.2018.08.900 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract: P1.13-43 -- Source: Wos |
